New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

At EAN 2024, Kristian Steen Frederiksen from the Danish Dementia Research Center chaired a session that broadly focused on the ongoing steps forward in understanding the pathophysiology and disease mechanisms of Alzheimer’s disease. In this MEDtalk, he briefly discusses some of the session’s highlights.